Drug Type CAR-NK |
Synonyms |
Target |
Action modulators |
Mechanism HLA-DRB1 modulators(major histocompatibility complex, class II, DR beta 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | Japan | 24 Mar 2025 |